Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Impact of 18F-Labeled Fluorodeoxyglucose Positron...
Journal article

Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer

Abstract

PURPOSE: Patients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment consists of curative intent combined modality therapy (neoadjuvant chemotherapy, surgery, and regional radiation). Positron emission tomography-computed tomography (PET-CT) may detect more asymptomatic distant metastases, but the evidence is based on uncontrolled studies. METHODS: For …

Authors

Dayes IS; Metser U; Hodgson N; Parpia S; Eisen AF; George R; Blanchette P; Cil TD; Arnaout A; Chan A

Journal

Journal of Clinical Oncology, Vol. 41, No. 23, pp. 3909–3916

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

August 10, 2023

DOI

10.1200/jco.23.00249

ISSN

0732-183X